NEC Moves Beyond IT Tools As It Pursues AI-Driven Drug Discovery Initiative

In an exclusive interview, Japanese tech giant NEC tells Scrip it is aiming for much more than the provision of IT tools in its AI-assisted Drug Discovery Initiative, hoping also to progress assets deriving from cutting-edge technology research. 

Osamu Fujikawa
NEC's Osamu Fujikawa • Source: NEC

More from AI

More from Digital Technologies